Health News (Reuters)

Sanofi beefs up diabetes pipeline to retrieve success

PARIS (Reuters) - Sanofi sees a more diversified pipeline driving a return to growth at its diabetes unit in the coming years and will consider acquisitions and partnerships to help boost performance, a company executive said on Tuesday.

U.S. defibrillator probe reduced questionable implantation rate

(Reuters Health) - A U.S. government investigation of allegations that doctors were implanting heart-shocking defibrillators into patients who didn't meet federal guidelines led to a dramatic reduction in the number of implants and may have saved many patients from unnecessary surgery, researchers report in the Journal of the American Medical Association.The 2010 Department of Justice probe involved Medicare recipients, but the new research also documents a comparable drop in defibrillator usage

Minor stroke needs quick medical attention, too

(Reuters Health) - Minor strokes and "mini-strokes," or transient ischemic attacks (TIAs), need early medical attention, just like major strokes, but a public education campaign in the UK had little success convincing the public to act fast after these events.

Sanofi beefing up diabetes pipeline, sees growth returning

PARIS (Reuters) - Sanofi sees a more diversified pipeline driving a return to growth at its diabetes unit in the coming years and will consider acquisitions and partnerships to help boost performance, a company executive said on Tuesday.

Trump administration names new U.S. drug enforcement chief

(Reuters) - The Trump administration on Monday named a top White House lawyer as the new head of the U.S. Drug Enforcement Administration after the agency's prior acting administrator announced his retirement last month.

Romania reports African swine fever in farm pigs

BUCHAREST (Reuters) - Romania has reported an outbreak of African swine fever at a breeding farm for pigs in the southern county of Tulcea, the national food safety authority ANSVSA said on Monday.

Roche 'highly encouraged' by Tecentriq results in breast cancer

ZURICH (Reuters) - Swiss drugmaker Roche said on Monday that a trial showed its immunotherapy Tecentriq plus the chemotherapy Abraxane significantly reduced the risk of disease worsening or death in people with metastatic triple negative breast cancer.

Britain's health service has started planning for Brexit no deal

LONDON (Reuters) - Britain's public health service has started "significant planning" to ensure medicines are still supplied to patients if the government fails to negotiate a Brexit deal with the European Union, its head said on Sunday.

Pages